Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Baker

Vascular Neurology Chesapeake, VA Medical Doctor

NPI 1043294663 CMS profile 318932

300 Medical Pkwy Ste 212, Chesapeake, VA 23320

Open in the dashboard

General payments

$10,530

145 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Baker of Chesapeake, VA is reported in the CMS Open Payments database as having received $10,530 across 145 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $541 15
2024 General $1,052 22
2023 General $1,980 27
2022 General $1,154 29
2021 General $3,750 16
2020 General $407 20
2019 General $1,645 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Baker
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to John Baker were reported at $541. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year John Baker Vascular Neurology median Middle half National median
2019 $1,645 $263 $102–$1,640 $163
2020 $407 $153 $45–$1,000 $114
2021 $3,750 $261 $100–$1,355 $132
2022 $1,154 $242 $87–$1,273 $149
2023 $1,980 $322 $97–$1,266 $160
2024 $1,052 $247 $70–$1,053 $164
2025 $541 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Silk Road Medical, Inc. $3,579 7 payments
  2. Stryker Corporation $2,098 27 payments
  3. Medtronic USA, Inc. $1,854 27 payments
  4. Medtronic, Inc. $746 24 payments
  5. Penumbra, Inc. $606 15 payments
  6. Imperative Care, INc $370 8 payments
  7. Rapid Medical LTD $288 5 payments
  8. DePuy Synthes Sales Inc. $251 6 payments
  9. Eisai Inc. $125 1 payment
  10. Mallinckrodt Hospital Products Inc. $97 1 payment
  11. Other $517 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,982 134 payments
  2. Consulting Fee $3,000 1 payment
  3. Travel and Lodging $2,548 10 payments
Products named General payments · program years 2019–2025
  1. ENROUTE Transcarotid Stent $3,527 6 payments
  2. ENROUTE Transcarotid Neuroprotection System $3,527 6 payments
  3. ENHANCE Transcarotid Peripheral Access Kit $3,314 4 payments
  4. ENROUTE .014 Guidewire $3,314 4 payments
  5. Pipeline Flow Diversion $1,567 18 payments
  6. POWER-PRO $972 3 payments
  7. Penumbra System $487 9 payments
  8. SURPASS EVOLVE $470 8 payments
  9. Pipeline Flow Diversion $436 14 payments
  10. TARGET $401 4 payments
  11. Other $3,668 97 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$69,424

Medicare's payments for the services billed

Medicare patients

136

Average age 74

Services billed

479

87 women, 49 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Diabetes 38%
Ischemic heart disease 38%
Depression 38%
Chronic kidney disease 28%
Heart failure 25%
COPD 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Leqembi
  • Eisai Inc. $125
$125 — —
ACTHAR
  • Mallinckrodt Hospital Products Inc. $97
$97 — —
Briviact
  • UCB, Inc. $35
$35 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

145 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record